ATP induces release of newly synthesized dopamine in the rat striatum

Neurochemistry International

Volumn 28, Issue 4, 1996, Pages 395-400

  Zhang, Yu Xiang ^a   Yamashita, Hiroshi ^a   Ohshita, Tomohiro ^a   Sawamoto, Nobukatsu ^a   Nakamura, Shigenobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CIBACRON BLUE F3GA; DOPAMINE; HOMOVANILLIC ACID; METIROSINE; OMEGA CONOTOXIN; PURINE P2Y RECEPTOR; RESERPINE; SODIUM CHANNEL; SURAMIN; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; DOPAMINE METABOLISM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029876225     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00105-0     Document Type: Article

References (25)

1. 2-purinoceptors on beta cell and pancreatic vascular bed. Br. J. Pharmac. 91, 783-787.
2. 2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmac. Sci. 11, 34-37.
3. Chiueh C. C. and Moore K. E. (1975) D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. J. Pharmac. exp. Ther. 192, 642-653.
4. Dahlquist R. and Diamant B. (1974) Interaction of ATP and calcium on the rat mast cell: effect on histamine release. Acta. Pharmac. Toxic. Copenh. 34, 368-384.
5. 2-purinoceptor antagonist in the mouse vas deferens. Br. J. Pharmac. 93, 243-245.
6. Fredholm B. B. and Dunwiddie T. V. (1988) How does adenosine inhibit transmitter release? Trends Pharmac. Sci. 9, 130-134.
7. Fredholm B. B., Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P. and Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmac. Rev. 46, 143-156.
8. Gordon J. L. (1986) Extracellular ATP: effects, source and fate. Biochem. J. 233, 309-319.
9. 2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5′-triphosphate. Br. J. Pharmac. 105, 453-457.
10. Inoue K., Nakazawa K., Fujimori K. and Takanaka A. (1989) Extracellular adenosine 5′-triphosphate-evoked norepinephrine secretion not relating to voltage-gated Ca channels in pheochromocytoma cells. Neurosci. Lett. 106, 294-299.
11. Lee K. and Tsien R. W. (1984) Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 302, 538-544.
12. Lentzen H. and Philippu A. (1981) Physico-chemical properties of phenethylamines and their uptake into synaptic vesicles of the caudate nucleus. Biochem. Pharmac. 30, 1759-1764.
13. McMillan B. A. (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmac. Sci. 4, 429-432.
14. McGraw C. F., Somlyo A. V. and Blaustein M. P. (1980) Localization of calcium in presynaptic nerve terminals: an ultrastructural and electron microprobe analysis. J. Cell Biol. 85, 228-241.
15. Nassar G. V. and Luxoro M. (1992) Catecholamine secretion from adrenal chromaffin cells of the toad (Caudiverbera caudiverbera): effect of monensin. Comp. Biochem. Physiol. comp. Pharmac. 101, 219-225.
16. Paxinos G. and Watson C. (1982) The Rat Brain in Stereo taxic Coordinates. Academic Press, London.
17. Phillis J. W. and Wu P. H. (1981) The role of adenosine and its nucleotides in central synaptic transmission. Neuroscience 16, 187-199.
18. Roth R. H., Murrin L. C. and Walters J. R. (1976) Central dopaminergic neurons: effects of alteration of impulse flow in the accumulation of dihydroxyphenylacetic acid. Eur. J. Pharmac. 36, 163-168.
19. Sela D., Ram E. and Atlas D. (1991) ATP receptor, a putative receptor-operated channel in PC-12 cells. J. biol. Chem. 266, 17,990-17,994.
20. Stone T. W. (1981) Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience 6, 523-555.
21. 2+ store of nonmuscle cells? Proc. natn. Acad. Sci. U.S.A. 85, 1091-1095.
22. Widerlov E. and Lewander T. (1978) The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats. Naunyn. Schmiedebergs Arch. Pharmac. 304, 125-134.
23. White T. D. (1988) Role of adenine compounds in autonomic neurotransmission. Pharmac. Ther. 38, 129-168.
24. Wood P. L. and Altar C. A. (1988) Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmac. Rev. 40(3), 163-187.
25. Zetterstrom T., Sharp T. and Ungerstedt U. (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: an in vivo brain dialysis study. Eur. J. Pharmac. 132, 1-9.